Viscoelastic and smart swelling disposition of Carboxymethylcellulose based hydrogels substantiated by Gemini surfactant and in-vitro encapsulation and controlled release of Quercetin

• Published in: International journal of biological macromolecules Vol. 207; pp. 374 - 386
• Main Authors: Bhat, Mushtaq A., Rather, Reyaz A., Yaseen, Zahid, Shalla, Aabid H.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 15.05.2022
• Subjects: Gemini surfactant; Hydrogel; Quercetin; Gemini surfactant; Quercetin; Hydrogel
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2022.02.162

CMC-SA-12-E2-12 hydrogels were prepared from Carboxymethylcellulose (CMC), succinic acid (SA) (biocompatible cross-linker) and Ethane-1,2-diyl-bis(N, N-dimethyl-N-dodecylammoniumacetoxy) (referred as 12-E2-12) (0.0006, 0.0015, 0.003, 0.0045 mMoles) by thermal treatment with economical and easy solution polymerization strategy. The CMC-SA-12E2-12 hydrogels were characterized for mechanical and viscoelastic properties like self-healing, viscosity and modulus using rheological analysis. Further the structural, morphological and thermal properties were investigated by FTIR, SEM and TGA analysis. The investigation revealed significant modulation in mechanical, viscoelastic, self-healing and drug release behavior with the addition of 12-E2-12. The CMC-SA-12-E2-12 hydrogels were investigated for drug release studies in PBS 7.4 for 48 h using Quercetin dihydrate. The results showed sustained release behavior at optimised concentration values of surfactant. Release data fitted nicely to the Higuchi model and hence the release could be seen to be diffusion controlled phenomenon or Fickian diffusion. The biocompatibility of cross-linker and surfactant may potentially make the hydrogels suitable for drug delivery applications. [Display omitted] •Synthesis and swelling of hydrogel relying on pH of the solution.•Mechanical properties showed dependence on surfactant concentrations.•Hydrogel showed thixotropic behavior.•Sustained drug release achieved in presence of 12-E2-12 at optimised values.